Bill C-45 is the catalyst the industry has been awaiting for several years, GMP says

There’s a strong likelihood that Canada’s Cannabis Act will get approved this summer, says GMP Securities’ Martin Landry, who in an update to clients on Tuesday said that Canada’s marijuana stocks should rally on news of the Senate passing Bill C-45, scheduled for third reading on June 7.

Landry says that on Monday, GMP met with representatives from Global Public Affairs, a firm which has been involved in Canada’s emerging cannabis space, who related that there is high likelihood that the Cannabis Act will receive Royal Assent (GPA gave it a roughly 85 per cent chance of success).

“GPA’s view echoes our own opinion that there are limited risks of Bill C-45 derailing at this point,” says Landry. “The Trudeau government has indicated clearly its support for the bill as part of its electoral platform. In addition, the provinces have deployed significant resources to prepare for this change. Hence, we would advise investors to remain invested in the cannabis sector ahead of Bill C-45 getting Royal Assent, as this is likely to be a catalyst the industry has been awaiting for several years.”

The legislative process will see the Senate send the two bills back to the House of Commons to approve a list of amendments, and then, once the amendment process concludes, the legislation will return to the Senate for Royal Assent.

Landry makes note of a number of amendments which may impact how the industry will unfold, including suggested THC limits and a restriction against brand stretching (using cannabis brand elements on promotional items such as clothing). He relates that GPA feels that while THC limits will likely be imposed, there is little risk of them being set so low that they will significantly impact the types of products permitted on the marketplace. As far as brand stretching goes, GPA believes that an amendment with such restrictions is not likely to be adopted by the House of Commons, given that it could be susceptible to free speech-based constitutional challenges.

GPA also related that given the high profile of Bill C-45, MPs and Senators are likely to extend their sessions past the June 29 summer recess date, if it turns out that ironing out the legislation’s amendments takes them past the end of June.

Landry says after the potential catalyst of the June 7 Senate vote, the cannabis sector could enter a brief lull in the summer followed by more upward movement potentially coinciding with the opening of Canada’s rec cannabis market, estimated to commence by late summer.

“In our view, the media attention around the first recreational sales could create excitement providing another positive catalyst for the sector,” says Landry.

More Cantech Cannabis

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago